Concepedia

Ludmila Kryzhanovskaya

LK

19

Publications

1.4K

Citations

16

H-Index

1999

Active since

Affiliations

Eli Lilly (United States)(Current)

McLean Hospital

Indiana University School of Medicine

The University of Texas Health Science Center at San Antonio

Indiana University – Purdue University Indianapolis

Ludmila Kryzhanovskaya is an author at Eli Lilly (United States) specializing in psychiatry, medicine, and schizophrenia.

Top concepts

Publications per year

1999–2025

19

Publications

19

Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania

Mauricio Tohen, Ludmila Kryzhanovskaya, Gabrielle A. Carlson et al. · American Journal of Psychiatry · 2007 · 314 citations

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

Bruce J. Kinon, Lu Zhang, Brian A. Millen et al. · Journal of Clinical Psychopharmacology · 2011 · 254 citations

, , +19

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Ludmila Kryzhanovskaya, S. Charles Schulz, Christopher J. McDougle et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2008 · 157 citations

, , +10

Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania

Mauricio Tohen, Eduard Vieta, Guy M. Goodwin et al. · The Journal of Clinical Psychiatry · 2008 · 87 citations

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder

Mary C. Zanarini, S. Charles Schulz, Holland C. Detke et al. · The Journal of Clinical Psychiatry · 2011 · 81 citations

Rows per page

1–5 of 19